Sitagliptin phosphate monohydrate

Sitagliptin phosphate monohydrate

Sitagliptin ( trade name Januvia) is an orally bioavailable dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type-2 diabetes. Sitagliptin has been approved by the U.S Food and Drug Administration on Oct 17, 2006.

Specifications

Product Name:                  Sitagliptin phosphate monohydrate

Synonyms:                         MK-0431

CAS Number:                     654671-77-9

Molecular Weight:            523.32806

Molecular Formula:          C16H20F6N5O6P

Purity (HPLC):                     ≥99%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OP(=O)(O)O.NC(Cc1cc(F)c(cc1F)F)CC(=O)N1CCn2c(C1)nnc2C(F)(F)F.O

  • $138.00
  • Ex Tax: $138.00

Available Options